Scientific Sessions 2025  /  Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI  /  Precision Medicine in AMI Care: Pharmacogenomics and Personalized Therapy
Logo

American Heart Association

  37
  0

Final ID:

Precision Medicine in AMI Care: Pharmacogenomics and Personalized Therapy

  • Defilippi, Christopher  ( Inova , Falls Church , Virginia , United States )
    • Author Disclosures:
    Christopher deFilippi: DO have relevant financial relationships ; Consultant:Abbott Diagnostics:Active (exists now) ; Other (please indicate in the box next to the company name):U of WA- CHS working group Co-Chair:Active (exists now) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Consultant:Tosoh:Active (exists now) ; Other (please indicate in the box next to the company name):Polymedco- speaker:Past (completed) ; Consultant:Siemens Healthineers:Active (exists now) ; Research Funding (PI or named investigator):Roche Diagnostics:Expected (by end of conference) ; Consultant:Roche Diagnostics:Active (exists now) ; Consultant:Quidel:Ortho:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Beyond Reperfusion: Cardiomyocyte Regeneration in AMI – Hype or Hope?

Pompilio Giulio, Janssens Stefan

Next-Gen Antiplatelet and Anticoagulant Therapies in AMI: Moving Beyond the Standard of Care

Rymer Jennifer

You have to be authorized to contact abstract author. Please, Login
Not Available